• Aucun résultat trouvé

Why do physicians prescribe antibiotics?

N/A
N/A
Protected

Academic year: 2021

Partager "Why do physicians prescribe antibiotics?"

Copied!
1
0
0

Texte intégral

(1)

E D I T O R I A L

Why do physicians prescribe antibiotics?

C. Ruef

Published online: 9 August 2011 Ó Springer-Verlag 2011

The superficial reader would answer this question thus: ‘‘Because the patient has an infection.’’ The more informed reader knows that a relevant proportion of antibiotics is prescribed to patients that do not have a bacterial infection and, therefore, do not benefit from such antibiotic treat-ment. The reasons for the overprescription of antibiotics have been investigated in numerous studies. One major reason for overprescription lies in the fact that it is clini-cally often difficult to determine at the outset whether the patient has a bacterial infection or not. The physician is, therefore, faced with the challenge to perform a risk assessment during which he or she weighs the benefits and disadvantages of giving or withholding antibiotics. If antibiotics are not given, patients with serious bacterial infections may face the risk of rapid progression of the infection and, potentially, a lethal outcome. Under such circumstances, it is understandable that physicians may decide to err on the safe side and to prescribe antibiotics. Another situation which may result in overprescription is the pressure and the expectation of the patient or the par-ents of patipar-ents to receive antibiotics for a clinical illness, which, in the eye of the patient, is disturbing and calls for antibiotic treatment.

Several other studies have shown that educational activities on the proper use or misuse of antibiotics may have a positive impact on the prescribing habits of physi-cians. Such studies are important, as the overuse of anti-biotics remains an important driving force for the development of antibiotic resistance all over the world.

In order to better target the content of such educational activities, it is important to understand the reasons for antibiotic prescription in the physician populations of a given country or area. The study by Velasco et al. in this issue of INFECTION provides some important insight into the factors that influence physicians’ decisions to prescribe antibiotics, which are not directly related to the clinical situation of patients, but are, rather, influenced by socio-behavioral characteristics [1]. Among the parameters identified in this survey of German physicians, which are not directly related to the physician–patient relationship, male sex, practicing in the eastern states of Germany, and having had negative experiences with failed therapies were predictors for a higher likelihood of antibiotic prescription compared with colleagues that did not share these charac-teristics. Although the results of this survey with a response rate of 33% must be interpreted with caution, the findings are certainly interesting and point out a need to take into account such socio-behavioral factors when planning con-tinuous medical education activities on the topic of anti-biotic use.

C. Ruef, Editor-in-Chief, INFECTION

Reference

1. Velasco E, Espelage W, Faber M, Noll I, Ziegelmann A, Krause G, Eckmanns T. A national cross-sectional study on socio-behav-ioural factors that influence physicians’ decisions to begin antimicrobial therapy. Infection. 2011;39. doi: 10.1007/s15010-011-0137-1

C. Ruef (&)

Division of Infectious Diseases and Hospital Epidemiology, HAL 14C, University Hospital of Zurich, 8091 Zurich, Switzerland

e-mail: christian.ruef@usz.ch

123

Infection (2011) 39:287 DOI 10.1007/s15010-011-0169-6

Références

Documents relatifs

Un second questionnaire a été diffusé auprès des médecins des établissements du réseau « Bretagne recherche clinique hospitalière » (BREC’H) : centre hospitalier

The second level of drug cost transparency involves automatically displaying the costs of alternative drugs within the same therapeu- tic category as the medication the

In 2015, the Canadian Task Force on Preventive Health Care (CTFPHC) released its “Recommendations for prevention of weight gain and use of behavioural and pharmacologic

Given the high proportion of individu- als in Canada who are overweight or obese, and the potential health benefits to patients of losing even 5% to 10% of their body weight,

2 In contrast, 2 studies of patients following a lifestyle program and randomized to placebo or medication (orli- stat or 3.0 mg of liraglutide in 4- and 3-year long stud-

First, I am concerned about my opponents’ worry that the weak recommendation from the Canadian Task Force on Preventive Health Care (CTFPHC) 2 against pharmaco- therapy will

Although many of the criticisms around current guide- line development offered by our colleagues are certainly relevant and very important, the suggestion that our

Among the Canadian CAFPs in our study, age and practising in the Prairies, and to a lesser extent practis- ing in the Atlantic Provinces, were the most powerful